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Background: Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important infectious
agents for the swine industry worldwide. Zinc (Zn) salts, which are widely used as a dietary supplement in swine
nutrition, have shown antiviral effects in vitro as well as in vivo. The purpose of this study was to determine the
influence of dietary zinc oxide supplementation on vaccination and challenge infection with PRRSV.
Findings: The clinical course of PRRS and the success of vaccination with an experimental inactivated vaccine were
compared between animals receiving a conventional diet (50 ppm Zn, control group) and diets supplemented with
Zn oxide (ZnO) at final Zn concentrations of 150 or 2,500 ppm. Pigs receiving higher dietary Zn levels showed a
tendency towards higher neutralizing antibody levels after infection, while dietary Zn levels did not substantially
influence the number of antiviral IFN-gamma secreting cells (IFN-gamma-SC) or percentages of blood immune cell
subsets after infection. Finally, feeding higher dietary Zn levels reduced neither clinical symptoms nor viral loads.
Conclusions: Our results suggest that higher levels of dietary ZnO do not have the potential to stimulate or
modulate systemic immune responses after vaccination and heterologous PRRSV infection to an extent that could
improve the clinical and virological outcome.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is
one of the most significant swine diseases worldwide [1].
Efficient PRRS virus (PRRSV) vaccines would be invalu-
able in minimizing the clinical and economic impact of
PRRSV infections, but currently safe and effective vaccines
which protect against a wide variety of strains are not
available [2].
Zinc (Zn) ion salts exhibit a broad-spectrum antiviral
activity against a variety of viruses in vitro, including the
animal viruses equine arteritis virus and transmissible* Correspondence: burwinkelm@rki.de
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unless otherwise stated.gastroenteritis virus [3,4]. In the European Union standard
dietary Zn levels in feedingstuffs are limited to 150 ppm
due to environmental reasons. However, in other countries
high levels of in-feed Zn oxide (ZnO, 2,000-3,000 ppm)
may be added to the diet of pigs during a restricted period
following weaning to prevent post-weaning diarrhea [5] as
high levels of ZnO have been proven to conserve the intes-
tinal flora during the critical period following the change of
diet that place at weaning [6]. Despite this effect, the exact
mechanisms of ZnO action remain uncertain, and the local
or systemic effects of ZnO against specific viral pathogens
also remain largely unknown.
We evaluated the systemic effects of different Zn levels
added to a conventional diet containing 50 ppm Zn
(Znlow, control group) against PRRSV. Two other groups
were fed the diet supplemented with ZnO at finald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Zn (Znhigh). Half of the animals received a single vaccin-
ation with an experimental UV-inactivated type I
PRRSV (Lelystad virus; LV), since it was shown that a
similar vaccination with such a virus in combination
with a suitable adjuvant could strongly prime the virus-
neutralizing (VN) response and reduce duration of
viremia after homologous challenge [7]. In contrast to
Vanhee et al., we chose a single-vaccination approach
and challenge-infected the animals with a heterologous
type I PRRSV (95,38% sequence identity for the enve-
lope glycoprotein GP5, which bears a major neutralizing
epitope) in order test the influence of elevated Zn levels
on an suboptimal antigen stimulus and on cross-
protection.
Methods
The study was approved by the local animal welfare au-
thority (Landesamt für Gesundheit und Soziales, Berlin,
Germany) under the registration number G 0116/12.
German Landrace piglets (n = 72) of both sexes from a
PRRSV-free herd were weaned at the age of 28 days,
moved to a biosafety level 2 experimental facility (Bun-
desinstitut für Risikobewertung, Berlin, Germany), and
randomly allocated to six pens (n = 12 per pen). Piglets
were assigned to three different diets (2 pens per diet).
At the age of 63 days, the animals receiving the Znhigh
diet were switched to the Znmed diet, in order to avoid
toxic effects of Zn. One week after commencing the dif-
ferent diets, one pen per diet was chosen randomly and
the animals were vaccinated intramuscularly with inacti-
vated LV (accession M96262; kindly provided by Prof. H.
Nauwynck (Ghent University, Ghent, Belgium)). Four
weeks after vaccination, at the age of 63 days, all pigs
were challenged with PRRSV field strain CReSA 3267
(accession JF276435; kindly provided by Prof. J. Segalés
and Prof. E. Mateu (CReSA, Barcelona, Spain). Animals
were infected by intranasal application of 1 ml of virus
suspension with a titer of 5 × 106 TCID50/ml to each
nostril using a spray nebulizer.
Pigs were monitored daily for the presence of clinical
signs and body weights were recorded weekly. Blood
samples were collected weekly after vaccination and at
0, 4, 7, 14, 21, 28, and 35 days post infection (dpi). Nasal
swabs were taken on the same dpi as blood samples for
quantification of virus shedding. All pigs were necrop-
sied on day 35 pi. Lung and lymphoid tissues were eval-
uated by visual inspection for macroscopic lesions, and
samples from lungs, lymph nodes, tonsils, and spleen
were taken and immediately frozen in liquid nitrogen
and stored at −70°C.
For virological analysis, serum samples (4, 7, 14, 21, 28
dpi), nasal swabs (4, 7, 14 dpi), and tonsil, lung and tracheo-
bronchial lymph node samples (35 dpi) were examined byqPCR to determine PRRSV copy numbers. RNA extraction
was performed using a viral RNA/DNA purification kit
(Stratec) applying 200 μl of serum or 10 mg of tissue each.
RNA yields and quality were determined with a NanoDrop®
ND-100 spectrophotometer (NanoDrop Technologies). Re-
verse transcription (RT) was performed using the Dy-
NAmo™ cDNA Synthesis Kit (Thermo Fisher Scientific).
Viral loads were quantified using a TaqMan fluorescent
probe-based real-time qPCR assay in an iCycler iQ™5 detec-
tion system (Bio-Rad) with primers described elsewhere [8].
PRRSV-specific IgM and IgG antibodies were mea-
sured by ELISA (Ingezim PRRS DR, Ingenasa) according
to the manufacturer’s instructions. VN antibodies against
PRRSV were quantified by a viral neutralization test as
previously described [9]. Neutralization of PRRSV strain
CReSA 3267 was examined using PRRSV GP5 specific
monoclonal antibody 3H4 (Ingenasa) and Alexa Fluor™
488 conjugated anti-mouse IgG (H + L) secondary anti-
body (Invitrogen).
Peripheral blood mononuclear cells (PBMC) were iso-
lated using density centrifugation through a Ficoll gradient
(LSM1077, PAA Laboratories). Samples were treated with
erythrocyte lysis buffer for 5 min on ice, PBMC were
washed with 10 ml of PBS with 0.2% BSA and centrifuged
for 15 min at 700 × g at 4°C. In all samples, PBMC viabil-
ity was confirmed using standard procedures.
The cell-mediated PRRSV-specific immune response
was measured by using ELISpot for the enumeration of
IFN-gamma-SC in PBMC (Mabtech). In order to com-
pare homologous and heterologous responses, PBMC
were stimulated in parallel (2.5 × 105 PBMC/well, 3
wells per pig and stimulus) with CReSA 3267 or LV at a
multiplicity of infection of 0.1. Unstimulated and PHA-
stimulated cells (10 μg/ml) were used as negative and
positive controls, respectively. IFN-gamma-SC numbers
were counted using an ELISpot Reader System (A.EL.
VIS GmbH).
Flow cytometry analysis was performed as described
before [10] using a BD FACSCanto™ flow cytometer (BD
Biosciences). Data were analyzed with FlowJo™ software
(TreeStar).
Results and discussion
Almost all infected pigs showed clinical symptoms typ-
ical for PRRSV infection and similar to a previous study
with the same PRRSV strain [11]. Increased rectal tem-
peratures were detected for more than 14 days, and
edema of the eyelids and conjunctivitis for more than
21 days. There was no significant dietary effect on fever
magnitude and duration (Figure 1 A,B). Other clinical
signs such as cough were observed only sporadically and
lasted only for 1–2 days. Regarding the weight gain, we
could only analyze the effect of the Znmed diet for the
vaccinated groups, given that 4 time points were missing
Figure 1 Body temperature and weekly weight gain in pigs infected with PRRSV strain CReSA 3267. A and B, Development of body
temperatures. Fever (body temperatures≥ 40°C) is indicated by the dotted line. C and D Weekly weight gains. Each bar represents the mean
value ± standard deviation from 12 pigs. Asterisks indicate differences (P < 0.05) between averages at each dpi calculated by Fisher’s Least
Significant Difference (LSD) test.
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time points as well as for the non-vaccinated groups we
found no benefits of feeding higher dietary Zn levels
(Figure 1 C,D).
Mean PRRSV load in serum as determined by qPCR
peaked at 4 dpi and gradually reduced later on. Neither
vaccination nor elevated Zn levels showed an influence
on PRRSV viremia at any time during the observation
period (Figure 2 A,B). The same was observed regard-
ing virus shedding as determined by analysis of nasal
swabs (Figure 2 C,D). Persistent virus was found at 35
dpi in the majority of tonsil samples, regardless of diet,
while all lung and tracheobronchial lymph node sam-
ples were tested negative for the presence of PRRSV
genomes.
PRRSV-specific IgG and IgM antibodies were not
detected by ELISA in randomly chosen samples (10 vac-
cinated/13 non-vaccinated) before infection on day 21
before infection. On day 0, only one vaccinated animal
was positive for PRRSV antibodies (Figure 3 A,B). This
is in contrast with previous results showing earlier sero-
conversion after vaccination with UV-inactivated LV
[7] and might be due to the fact that we used a cell cul-
ture-adapted non-purified LV with possibly decreased
immunogenicity compared to purified LV grown on por-
cine alveolar macrophages used in the cited study. At 7
dpi, piglets from all groups were seropositive, except for
1 pig each in the vaccinated and non-vaccinated Znlow
groups. Higher (P ≤ 0.01) antibody levels were detectedin vaccinated groups than in non-vaccinated groups at 7
and 21 dpi after PRRSV challenge, while the diet had no
influence on antibody levels.
The generation of neutralizing antibodies is delayed in
PRRSV infection and usually appears three to four weeks
after infection [12]. Accordingly, in our study virus neu-
tralizing VN antibodies were not detectable until 28 dpi in
the serum. A single-vaccination with an inactivated LV
did not lead to an earlier induction of VN antibodies, but
vaccinated groups developed higher (P = 0.045) VN anti-
body titers than their non-vaccinated counterparts at 35
dpi (Figure 3C, D). A tendency towards higher VN anti-
body levels was evident in pigs receiving higher levels of
Zn (Znmed) at 28 dpi. This tendency continued to 35 dpi
in both Znmed and Znhigh groups. Thus, the possibility re-
mains that animals receiving higher dietary Zn levels
might be better protected against reinfection with PRRSV.
The number of IFN-gamma-SC at 35 dpi revealed no dif-
ferences after homologous or heterologous re-stimulation
(Additional file 1). Flow cytometry analysis of PBMC pheno-
types was performed weekly from day 0 to day 35 post infec-
tion. Single vaccination only delayed but not prevented the
PRRSV-induced decrease of CD4+, CD8+ and CD4+CD8+ T
cell populations, which are important for viral clearance
[13]. We found no sustained effect of dietary Zn levels on
any of the analysed cell subsets (Additional file 2).
Necropsies at 35 dpi revealed no gross lung lesions
and lymphoid hyperplasia in tonsils, lymph nodes or
spleen in any of the pigs.
Figure 3 Development of humoral responses against PRRSV. A and B, PRRSV-specific antibodies measured by ELISA are shown as average
sample to positive (S/P) ratios of optical density (OD) from 4 to 35 dpi. Samples with S/P ratios < 0.175 were considered negative (broken line).
C and D, Serum neutralization tests were performed by a standard immunofluorescence assay and the results are shown as titers (log2). Samples
were considered negative when the dilution was lower than 1:4 (below broken line).
Figure 2 Detection of virus in sera, nasal swabs and tonsils by quantitative RT-PCR after PRRSV infection. Boxes indicate medians (n = 12,
horizontal lines) and the lower and upper quartiles (bottoms and tops of boxes). The vertical bars in the box plots indicate the minimal and
maximal values recorded. A and B, Mean viral loads (copy numbers/ml) in sera. C and D, Mean viral loads in nasal swabs and tonsils. The
detection limit was 6.3 × 101 copies/ml (broken line).
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a wild-type PRRSV without additional environmental
and social stress and the impact of secondary infections
results in relatively mild clinical signs. Under these con-
ditions, elevated dietary Zn levels could not provide en-
hanced protection against infection with a type I PRRSV
field strain and could not improve efficacy after a single-
vaccination with a heterologous inactivated vaccine.Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article (and its additional files).Additional files
Additional file 1: Figure S1. PRRSV-specific numbers of IFN-gamma-SC
determined by ELISpot. PBMC collected at 35 dpi were restimulated with
either of the PRRSV strains (LV or CReSA 3267) used in the study. Results
are shown as average frequencies of virus-specific IFN-gamma-SC per
2.5 × 105 PBMC. Filled symbols indicate results obtained after in vitro
restimulation with the same PRRSV used for infections (homologous)
while empty symbols show the results of in vitro restimulation with LV
(heterologous).
Additional file 2: Figure S2. Modulation of PBMC immune cells
frequencies determined by flow cytometry analysis. A and B, Cytotoxic
lymphocytes (CD3+CD4−CD8 αhigh); C and D, naïve TH cells (CD3+CD4+CD8−);
E and F, CD8+ γδ T cells (CD3+CD2+CD8+); G and H, Antibody forming and/
or memory B cells (CD3−CD2+CD21−); I and J, NK cells. Asterisks indicate
statistically significant differences (P < 0.05) between averages at each
dpi.Competing interests
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